Not applicableActive Not RecruitingNCT06523777What this trial is testingPRISM: Patient Experiences With PET Imaging in Prostate CancerWho this might be right forProstate Cancer Yale University 350
Not applicableEnrolling By InvitationNCT06424275What this trial is testingProstate Cancer Awareness and Initiative for Screening in the European UnionWho this might be right forProstate Cancer European Association of Urology Research Foundation 20,000
Not applicableStudy completedNCT05764330What this trial is testingWeight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active SurveillanceWho this might be right forProstate Carcinoma Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00589472What this trial is testingAndrogen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate CancerWho this might be right forProstate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more National Cancer Institute (NCI) 19
Not applicableUnknownNCT06091072What this trial is testingImage-guided Navigation During Robotic Sentinel Node RemovalWho this might be right forProstate Cancer The Netherlands Cancer Institute 55
Very early researchUnknownNCT05955677What this trial is testingHead-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and MetastasisWho this might be right forProstate CancerPET/CT Anhui Provincial Hospital 100
Not applicableEnded earlyNCT02131207What this trial is testingMRI Before Biopsy in Diagnosing Patients With Prostate CancerWho this might be right forProstate Cancer Case Comprehensive Cancer Center 139
Not applicableStudy completedNCT04421781What this trial is testingSalvage HIFU for Local Recurrence in the Prostatic Bed After Prostatectomy and External Beam Radiation Therapy : Preliminary ResultsWho this might be right forProstatic Cancer Hospices Civils de Lyon 22
Testing effectiveness (Phase 2)Study completedNCT00260611What this trial is testingStudy of Oxaliplatin and Taxotere in Prostate CancerWho this might be right forProstate Cancer University of Pittsburgh 34
Testing effectiveness (Phase 2)Study completedNCT04332744What this trial is testingEnzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)Who this might be right forMetastatic Prostate Cancer MedSIR 54
Not applicableStudy completedNCT02618200What this trial is testingCreation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate CancerWho this might be right forProstate Cancer Hospices Civils de Lyon 2
Testing effectiveness (Phase 2)Study completedNCT05407311What this trial is testing64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)Who this might be right forBiochemical Recurrence of Malignant Neoplasm of Prostate Clarity Pharmaceuticals Ltd 53
Not applicableStudy completedNCT02443571What this trial is testingRetrospective Observational Study Investigating Fluciclovine (18F) (FACBC)Who this might be right forProstatic Neoplasms Blue Earth Diagnostics 714
Large-scale testing (Phase 3)Active Not RecruitingNCT03531099What this trial is testingPhase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate CancerWho this might be right forProstate Cancer Hospices Civils de Lyon 108
Testing effectiveness (Phase 2)Study completedNCT00108732What this trial is testingA Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate CancerWho this might be right forRecurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more National Cancer Institute (NCI) 50
Early research (Phase 1)Ended earlyNCT01741753What this trial is testingBKM120+Abiraterone Acetate for Metastatic CRPCWho this might be right forProstate Cancer Dana-Farber Cancer Institute 4
Large-scale testing (Phase 3)Active Not RecruitingNCT04493853What this trial is testingCapivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN DeficiencyWho this might be right forHormone-Sensitive Prostate Cancer AstraZeneca 1,012
Early research (Phase 1)Study completedNCT00868595What this trial is testingMTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate CancerWho this might be right forCastrate Resistant Prostate Cancer (CRPC) Bellicum Pharmaceuticals 18
Not applicableUnknownNCT06677775What this trial is testingPathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative BiopsyWho this might be right forProstate Cancer Anhui Provincial Hospital 30
Not applicableActive Not RecruitingNCT04985565What this trial is testingNeoadjuvant Dietary Intervention in Intermediate Risk Prostate CancerWho this might be right forProstate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+4 more M.D. Anderson Cancer Center 12